Vanguard Group Inc Roivant Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 39,326,336 shares of ROIV stock, worth $455 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,326,336
Previous 40,767,590
3.54%
Holding current value
$455 Million
Previous $411 Million
7.75%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ROIV
# of Institutions
350Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$761 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$716 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$532 Million1.55% of portfolio
-
Morgan Stanley New York, NY35.9MShares$416 Million0.03% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...